Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revised ciprofloxacin dosing in renal impairment bioequivalence study
NL-OMON59996Phase 4Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2025
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ciprofloxacin, sponsored by Amsterdam University Medical Center. Started Jan 2025; status: recruiting.
02
Drugs
ciprofloxacin
Beyond the preview
Go deeper on NL-OMON59996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59996.